{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T05:54:38Z","timestamp":1789019678468,"version":"build-2803163510"},"reference-count":31,"publisher":"Pharmaceutical Society of Japan","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2020,10,1]]},"DOI":"10.1248\/bpb.b20-00262","type":"journal-article","created":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T22:12:57Z","timestamp":1601503977000},"page":"1511-1518","source":"Crossref","is-referenced-by-count":13,"title":["Oroxylin A Exerts Its Antitumor Effects in Human Gallbladder Cancer &lt;i&gt;via&lt;\/i&gt; Inhibition of the PTEN\/PI3K\/AKT Signaling Pathway"],"prefix":"10.1248","volume":"43","author":[{"given":"Liqian","family":"Xuan","sequence":"first","affiliation":[{"name":"Digestive Endoscopy Center, Department of Gastroenterology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Digestive Endoscopy Center, Department of Gastroenterology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianmei","family":"Ji","sequence":"additional","affiliation":[{"name":"Digestive Endoscopy Center, Department of Gastroenterology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Cholangio-pancreatic Surgery, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cholangio-pancreatic Surgery, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Miller G, Jarnagin WR. Gallbladder carcinoma. <i>Eur. J. Surg. Oncol.<\/i>, <b>34<\/b>, 306\u2013312 (2008).","DOI":"10.1016\/j.ejso.2007.07.206"},{"key":"2","unstructured":"2) Shirai Y, Wakai T, Hatakeyama K. Radical lymph node dissection for gallbladder cancer: indications and limitations. <i>Surg. Oncol. Clin. N. Am.<\/i>, <b>16<\/b>, 221\u2013232 (2007)."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Carnero A, Blanco-Aparicio C, Renner O, Link W, Leal JFM. The PTEN\/PI3K\/AKT signalling pathway in cancer, therapeutic implications. <i>Curr. Cancer Drug Targets<\/i>, <b>8<\/b>, 187\u2013198 (2008).","DOI":"10.2174\/156800908784293659"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Maehama T, Dixon JE. The tumor suppressor, PTEN\/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. <i>J. Biol. Chem.<\/i>, <b>273<\/b>, 13375\u201313378 (1998).","DOI":"10.1074\/jbc.273.22.13375"},{"key":"5","unstructured":"5) Maehama T, Taylor GS, Dixon JE. PTEN and myotubularin: novel phosphoinositide phosphatases. <i>Annu. Rev. Biochem.<\/i>, <b>70<\/b>, 247\u2013279 (2001)."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Bae IH, Park M-J, Yoon SH, Kang SW, Lee S-S, Choi K-M, Um H-D. Bcl-w promotes gastric cancer cell invasion by inducing matrix metalloproteinase-2 expression <i>via<\/i> phosphoinositide 3-kinase, Akt, and Sp1. <i>Cancer Res.<\/i>, <b>66<\/b>, 4991\u20134995 (2006).","DOI":"10.1158\/0008-5472.CAN-05-4254"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Skurk C, Maatz H, Kim H-S, Yang J, Abid MR, Aird WC, Walsh K. The Akt-regulated forkhead transcription factor FOXO3a controls endothelial cell viability through modulation of the caspase-8 inhibitor FLIP. <i>J. Biol. Chem.<\/i>, <b>279<\/b>, 1513\u20131525 (2004).","DOI":"10.1074\/jbc.M304736200"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Qian L, Li X, Ye P, Wang G, Dai W, Liu Y, Gao Q, Shen G. Oxymatrine induces apoptosis and inhibits invasion in gallbladder carcinoma <i>via<\/i> PTEN\/PI3K\/AKT pathway. <i>Cytotechnology<\/i>, <b>70<\/b>, 83\u201394 (2018).","DOI":"10.1007\/s10616-017-0153-9"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Wang C-G, Zhong L, Liu Y-L, Shi X-J, Shi L-Q, Zeng L, Liu B-Z. Emodin exerts an antiapoptotic effect on human chronic myelocytic leukemia K562 cell lines by targeting the PTEN\/PI3K-AKT signaling pathway and deleting BCR-ABL. <i>Integr. Cancer Ther.<\/i>, <b>16<\/b>, 526\u2013539 (2017).","DOI":"10.1177\/1534735416664784"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Qu J, Liu F, Zhang X, Wang J. Oroxylin A reduces vasoconstriction in rat aortic rings through promoting NO production and NOS protein expression <i>via<\/i> estrogen receptor signal pathway. <i>Evid. Based Complement. Alternat. Med.<\/i>, <b>2020<\/b>, 9257950 (2020).","DOI":"10.1155\/2020\/9257950"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Chen Y-C, Yang L-L, Lee TJ-F. Oroxylin A inhibition of lipopolysaccharide-induced iNOS and COX-2 gene expression <i>via<\/i> suppression of nuclear factor-\u03baB activation. <i>Biochem. Pharmacol.<\/i>, <b>59<\/b>, 1445\u20131457 (2000).","DOI":"10.1016\/S0006-2952(00)00255-0"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Li J, Tong D, Liu J, Chen F, Shen Y. Oroxylin A attenuates cigarette smoke-induced lung inflammation by activating Nrf2. <i>Int. Immunopharmacol.<\/i>, <b>40<\/b>, 524\u2013529 (2016).","DOI":"10.1016\/j.intimp.2016.10.011"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Yang X, Zhang F, Wang Y, Cai M, Wang Q, Guo Q, Li Z, Hu R. Oroxylin A inhibits colitis-associated carcinogenesis through modulating the IL-6\/STAT3 signaling pathway. <i>Inflamm. Bowel Dis.<\/i>, <b>19<\/b>, 1990\u20132000 (2013).","DOI":"10.1097\/MIB.0b013e318293c5e0"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Xu M, Lu N, Sun Z, Zhang H, Dai Q, Wei L, Li Z, You Q, Guo Q. Activation of the unfolded protein response contributed to the selective cytotoxicity of oroxylin A in human hepatocellular carcinoma HepG2 cells. <i>Toxicol. Lett.<\/i>, <b>212<\/b>, 113\u2013125 (2012).","DOI":"10.1016\/j.toxlet.2012.05.008"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Mikami T, Yanagisawa N, Baba H, Koike M, Okayasu I. Association of Bcl-2 protein expression with gallbladder carcinoma differentiation and progression and its relation to apoptosis. <i>Cancer<\/i>, <b>85<\/b>, 318\u2013325 (1999).","DOI":"10.1002\/(SICI)1097-0142(19990115)85:2<318::AID-CNCR8>3.0.CO;2-S"},{"key":"16","unstructured":"16) Turunen N, Paakko P, Soini Y. Apoptosis in gallbladder carcinomas and dysplasias, its relation to the expression of caspases 3, 6 and 8 and apoptosis regulating proteins bcl-2, mcl-1 and bax. <i>Histol. Histopathol.<\/i>, <b>15<\/b>, 53\u201360 (2000)."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Liu T-Y, Tan Z-J, Jiang L, Gu J-F, Wu X-S, Cao Y, Li M-L, Wu K-J, Liu Y-B. Curcumin induces apoptosis in gallbladder carcinoma cell line GBC-SD cells. <i>Cancer Cell Int.<\/i>, <b>13<\/b>, 64 (2013).","DOI":"10.1186\/1475-2867-13-64"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Srivastava K, Srivastava A, Mittal B. Caspase-8 polymorphisms and risk of gallbladder cancer in a Northern Indian population. <i>Mol. Carcinog.<\/i>, <b>49<\/b>, 684\u2013692 (2010).","DOI":"10.1002\/mc.20641"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Johansson N, Ahonen M, K\u00e4h\u00e4ri VM. Matrix metalloproteinases in tumor invasion. <i>Cell. Mol. Life Sci.<\/i>, <b>57<\/b>, 5\u201315 (2000).","DOI":"10.1007\/s000180050495"},{"key":"20","unstructured":"20) Hundal R, Shaffer EA. Gallbladder cancer: epidemiology and outcome. <i>Clin. Epidemiol.<\/i>, <b>6<\/b>, 99\u2013109 (2014)."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Sun Y, Lu N, Ling Y, Gao Y, Chen Y, Wang L, Hu R, Qi Q, Liu W, Yang Y, You Q, Guo Q. Oroxylin A suppresses invasion through down-regulating the expression of matrix metalloproteinase-2\/9 in MDA-MB-435 human breast cancer cells. <i>Eur. J. Pharmacol.<\/i>, <b>603<\/b>, 22\u201328 (2009).","DOI":"10.1016\/j.ejphar.2008.12.008"},{"key":"22","unstructured":"22) Wei L, Dai Q, Zhou Y, Zou M, Li Z, Lu N, Guo Q. Oroxylin A sensitizes non-small cell lung cancer cells to anoikis <i>via<\/i> glucose-deprivation-like mechanisms: c-Src and hexokinase II. <i>Biochim. Biophys. Acta<\/i>, <b>1830<\/b>, 3835\u20133845 (2013)."},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Pepper C, Hoy T, Bentley DP. Bcl-2\/Bax ratios in chronic lymphocytic leukaemia and their correlation with <i>in vitro<\/i> apoptosis and clinical resistance. <i>Br. J. Cancer<\/i>, <b>76<\/b>, 935\u2013938 (1997).","DOI":"10.1038\/bjc.1997.487"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Porter AG, J\u00e4nicke RU. Emerging roles of caspase-3 in apoptosis. <i>Cell Death Differ.<\/i>, <b>6<\/b>, 99\u2013104 (1999).","DOI":"10.1038\/sj.cdd.4400476"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Maurya SK, Tewari M, Sharma B, Shukla HS. Expression of procaspase 3 and activated caspase 3 and its relevance in hormone-responsive gallbladder carcinoma chemotherapy. <i>Korean J. Intern. Med.<\/i>, <b>28<\/b>, 573\u2013578 (2013).","DOI":"10.3904\/kjim.2013.28.5.573"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Zong H, Yin B, Chen J, Ma B, Cai D, He X. Over-expression of c-FLIP confers the resistance to TRAIL-induced apoptosis on gallbladder carcinoma. <i>Tohoku J. Exp. Med.<\/i>, <b>217<\/b>, 203\u2013208 (2009).","DOI":"10.1620\/tjem.217.203"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Fujiwara M, Muragaki Y, Ooshima A. Keloid-derived fibroblasts show increased secretion of factors involved in collagen turnover and depend on matrix metalloproteinase for migration. <i>Br. J. Dermatol.<\/i>, <b>153<\/b>, 295\u2013300 (2005).","DOI":"10.1111\/j.1365-2133.2005.06698.x"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Westermarck J, K\u00e4h\u00e4ri VM. Regulation of matrix metalloproteinase expression in tumor invasion. <i>FASEB J.<\/i>, <b>13<\/b>, 781\u2013792 (1999).","DOI":"10.1096\/fasebj.13.8.781"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Wan X, Helman LJ. Levels of PTEN protein modulate Akt phosphorylation on serine 473, but not on threonine 308, in IGF-II-overexpressing rhabdomyosarcomas cells. <i>Oncogene<\/i>, <b>22<\/b>, 8205\u20138211 (2003).","DOI":"10.1038\/sj.onc.1206878"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Zhang P, Guo Z, Wu Y, Hu R, Du J, He X, Jiao X, Zhu X. Histone deacetylase inhibitors inhibit the proliferation of gallbladder carcinoma cells by suppressing AKT\/mTOR signaling. <i>PLOS ONE<\/i>, <b>10<\/b>, e0136193 (2015).","DOI":"10.1371\/journal.pone.0136193"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Li C, Wang C, Xing Y, Zhen J, Ai Z. CD133 promotes gallbladder carcinoma cell migration through activating Akt phosphorylation. <i>Oncotarget<\/i>, <b>7<\/b>, 17751\u201317759 (2016).","DOI":"10.18632\/oncotarget.7474"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/43\/10\/43_b20-00262\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,3]],"date-time":"2020-10-03T03:12:39Z","timestamp":1601694759000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/43\/10\/43_b20-00262\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,1]]},"references-count":31,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b20-00262","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,1]]}}}